CR6300A - NEW ORAL FORMULATION - Google Patents

NEW ORAL FORMULATION

Info

Publication number
CR6300A
CR6300A CR6300A CR6300A CR6300A CR 6300 A CR6300 A CR 6300A CR 6300 A CR6300 A CR 6300A CR 6300 A CR6300 A CR 6300A CR 6300 A CR6300 A CR 6300A
Authority
CR
Costa Rica
Prior art keywords
oral formulation
new oral
composition
new
active agents
Prior art date
Application number
CR6300A
Other languages
Spanish (es)
Inventor
Bruijn Karel De
Gunter Engel
Hans Jurgen Pfannkuche
Michael Thewisen
Christian Vitzling
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to CR6300A priority Critical patent/CR6300A/en
Publication of CR6300A publication Critical patent/CR6300A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica, en particular a una composición para administrar agentes activos que sean pobremente solubles en medios acuosos, y/o que sean sensibles al ácido.The present invention relates to a pharmaceutical composition, in particular to a composition for administering active agents that are poorly soluble in aqueous media, and / or that are acid sensitive.

CR6300A 2001-01-26 2001-01-26 NEW ORAL FORMULATION CR6300A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CR6300A CR6300A (en) 2001-01-26 2001-01-26 NEW ORAL FORMULATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CR6300A CR6300A (en) 2001-01-26 2001-01-26 NEW ORAL FORMULATION

Publications (1)

Publication Number Publication Date
CR6300A true CR6300A (en) 2004-06-08

Family

ID=51359471

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6300A CR6300A (en) 2001-01-26 2001-01-26 NEW ORAL FORMULATION

Country Status (1)

Country Link
CR (1) CR6300A (en)

Similar Documents

Publication Publication Date Title
HUP0203204A2 (en) Oral dosage forms
AR033423A1 (en) PHARMACEUTICAL SALTS CONSTITUTED OF AN ACTIVE PHARMACEUTICAL SUBSTANCE AND AT LEAST A SWEETENER, MEDICATIONS CONTAINING THESE SALTS AND USE OF THESE SALTS FOR THE PREPARATION OF MEDICINES
HUP0203330A2 (en) Pharmaceutical compositions with improved solubility and oral absorptivity, containing benzamide derivatives
HUP0302086A2 (en) Oral pharmaceutical composition with a delayed action and process for its preparation
UA100966C2 (en) Oral pharmaceutical formulation based on 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid
YU8701A (en) New oral formulation
AR032293A1 (en) PHARMACEUTICAL CASE
ATE541562T1 (en) IBUPROFEN SUSPENSION
DE69923336D1 (en) ORANGE BUPRENORPHINIC MEDICINAL PRODUCTS TO BE APPLIED
NO20023551D0 (en) Ibuprofen-containing active agent preparation
ATE464878T1 (en) PHARMACEUTICAL COMPOSITION FOR NASAL USE OF FENTANYL
SE0001916D0 (en) Novel formulation
DE60004204D1 (en) PHARMACEUTICAL COMPOSITIONS INTENDED FOR THE ORAL ADMINISTRATION OF PHLOROGLUCINOL AND THE PRODUCTION THEREOF
DE60111503D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING TERBINAFIN
CR6300A (en) NEW ORAL FORMULATION
DK1273301T3 (en) Pharmaceuticals based on active ingredients that can be used for illicit administration
ECSP993104A (en) NEW ORAL FORMULATION
ATE357220T1 (en) MODIFIED RELEASE PHARMACEUTICAL COMPOSITION
UY27920A1 (en) COMBINATIONS OF EPINASTINE, PSEUDOEFEDRINE AND METHYLEDHEDRINE AS NEW PHARMACEUTICAL FORMULATIONS
DE60112578D1 (en) PHARMACEUTICAL DICLOFENAC COMPOUND BASED ON VITAMIN E, PAPAIN AND HYALURONIDASE
MY152490A (en) New oral formulation
NO20044519L (en) Hyperforin derivatives, their use and formulations containing them
TH51174A (en) New compound